Answers are grounded in this paper and cite their sources.
OBJECTIVE: To comprehensively describe the new syndrome of myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK), including cellular electrophysiological characterization of observed clinical improvement with fever. METHODS: 3.1 channels. RESULTS: 3.1, increasing channel availability. INTERPRETATION: 3.1 subunit-containing channels, which would counter the loss of function observed for mutant channels, highlighting KCNC1 as a potential target for precision therapeutics. Ann Neurol 2017;81:677-689.
No takes yet. Share an insight, caveat, or question.
Oliver et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: